|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
33.540 +4.180 (+14.237%) | 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/12 USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Turnover | 404,216 | -22.082% | 959,526 | 594,486 | 839,529 | 625,698 |
| Cost of Sales | (197,505) | -0.321% | (406,322) | (322,361) | (429,976) | (321,615) |
| Gross Profit | 206,711 | -35.530% | 553,204 | 272,125 | 409,553 | 304,083 |
| 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/12 USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (7,820) | -41.493% | (426,901) | (175,650) | 27,020 | 6,140 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (154,959) | -19.879% | (320,378) | (39,072) | (1,384) | (27) | |
| Profit / (Loss) before Taxation | (119,417) | 100250.420% | (470,533) | (170,797) | (350,979) | (431,690) | |
| Taxation | (9,927) | -59.362% | (61,871) | (2,977) | (4,142) | 3,719 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | 3,029,061 | -- | -- | |
| Non-controlling Interests | 1 | -- | (426) | 106,590 | 259,644 | 201,120 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (129,343) | 407.984% | (532,830) | 2,961,877 | (95,477) | (226,851) | |
| 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/12 USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Net Finance Costs / (Income) | (1,531) | -- | 17,294 | 8,032 | 27,510 | 13,269 |
| Depreciation & Amortisation | 40,420 | 15.843% | 74,039 | 61,538 | 74,046 | 64,248 |
| Directors' Emoluments | -- | -- | 3,202 | 3,194 | 2,479 | 3,042 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -5.920 | 401.695% | -24.580 | 139.630 | -4.530 | -10.820 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.150 | 0.036 | (0.136) | (0.057) |
| NBV per share ($) | 1.776 | -- | 1.811 | 2.016 | 0.655 | 0.478 |
| Remarks: | Real time quote last updated: 20/08/2026 10:04 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -129,343 |
| %Change | 407.984% |
| EPS / (LPS) | USD -0.059 |
| NBV Per Share ($) | USD 1.776 |